Skip to Content
scroll

Mayne Pharma Group Ltd (MYX)

ASX.MYX $0.39

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

ASX.MYX $0.39

20 MINUTE DELAYED

TODAY

1.32 %

1 YEAR RETURN

0.00%

VOLUME

3,371,476

DIV YIELD

0%

PE RATIO

0.00

52 WEEK RANGE

0.20

0.43

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

0.39

Change

0.01 (1.32)

Bid / Ask

0.38 - 0.39

Volume

3,371,476

Volume (3mths avg)

0

Turnover

1,274,405

Open

0.38

Day Range

0.37 - 0.39

VWAP

0.38

Prev Close

0.38

Last Trade

17/08 4:10pm (AEST)

i

KEY INFORMATION
Sector

Shares Issued

0

NTA/Share

0.00

Last Dividend

0.00

Dividend Ex Date

Dividend Pay Date

14 SEP 2011

i

BROKER CALLS

current

Mean

0.00

Target Price

0.00

i

CURRENT ()
Revenue

EBITDA

Profit

Earnings Per Share (EPS)

0.00

Dividend Per Share (DPS)

0.00

Yield %

0.00

Market Cap

0.00

Price to Earnings Ratio (P/E)

0

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

0.00

EBITDA

0.00

Profit

0.00

Earnings Per Share (EPS)

0.00

Dividend Per Share (DPS)

0.00

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation ()

0.00
image description

Business Summary

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing generic pharmaceuticals. The Company operates through four segments: Metrics Contract Services (MCS), International, Branded Products Division (BPD) and Portfolio Products Division (PPD). The MCS segment is engaged in providing contract pharmaceutical development, manufacturing and analytical services to third-party customers, principally in the United States. The PPD segment distributes established products (branded and generic) in the United States on a portfolio basis. The BPD segment distributes medically differentiated specialty products in United States. Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. Its products include Doxycycline Capsules, Oxycodone IR Tablets, Erythromycin Capsules and others.
image description

Relevant suggested news and content from the site

image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top